CMD-193

· Wyeth (Pfizer)

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for CMD-193, covering 2007-12-10 to 2020-08-10. Get the full timeline:

Most recent: Clinical Trial Update: Biodistribution Study of CMD-193 in Patients With Advanced Tumours Expressing the Lewis-Y Antigen [Phase 1]